contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


polarcool-signs-its-third-agreement-in-the-british-elite-ice-hockey-league-with-manchester-storm

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

PolarCool operates in the medical technology sector. The company focuses on products and solutions for injuries, primarily head injuries, from sports and activity. The main focus is on research and development of products used in the treatment of brain injuries, where the solutions are used by sports clubs, healthcare facilities and professional organizations. PolarCool was founded in 2017 and is held on a global level, with the largest presence in the European market.

PolarCool

The med-tech company PolarCool AB (publ.) has entered into an agreement with the professional ice hockey team Manchester Storm in the British Elite Ice Hockey League (EIHL). The club becomes...

The med-tech company PolarCool AB (publ.) has entered into an agreement with the professional ice hockey team Manchester Storm in the British Elite Ice Hockey League (EIHL). The club becomes the third team in the league to use PolarCap® for the acute treatment of concussions.&nbsp;With Manchester Storm as a new customer, PolarCool further expands its presence in the British top league, which consists of a total of ten teams from England, Northern Ireland, Scotland, and Wales. PolarCool already has agreements in place with Cardiff Devils and Sheffield Steelers for the use of PolarCap®.&nbsp;PolarCool's CEO, Erik Andersson, comments:&nbsp;-We are very pleased that Manchester Storm have chosen to provide PolarCap®. We are seeing increasing interest in the British league, and this agreement is an indication that our solution addresses a genuine need. We see strong potential for additional EIHL clubs to follow the clubs that now already provide PolarCap®.&nbsp;PolarCool currently has a strong customer base within European professional ice hockey, with teams using PolarCap® in top leagues across Sweden, Germany, Switzerland, Finland, Austria, France, the Czech Republic, and Slovakia. Manchester Storm will use PolarCap® for the remainder of the season during an initial evaluation period, with the possibility of continuing into a two-year commercial agreement following the evaluation. Although individual agreements may have limited financial impact, this marks an important step in PolarCool's long-term growth strategy and its ambition to strengthen its position in the European market.&nbsp;For more information Erik Andersson - CEO PolarCool AB (publ.)&nbsp; +46 - 73&nbsp;860 57 00&nbsp;&nbsp;&nbsp;&nbsp; E-mail: <a href="mailto:erik.andersson@polarcool.se">erik.andersson@polarcool.se</a>&nbsp;About PolarCool AB (publ.) PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and its shares are listed on Spotlight Stock Market.&nbsp;<div></div>

PolarCool Signs Its Third Agreement in the British Elite Ice Hockey League with Manchester Storm